The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

By Mizutani Y.   Wada H.   Fukushima M.   Yoshida O.   Ukimura O.   Kawauchi A.   Miki T.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 569-575

Elsevier

Access to resources Recommend Favorite

Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma

By Mizutani Y.   Wada H.   Yoshida O.   Fukushima M.   Nakanishi H.   Nakao M.   Miki T.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma

By            

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 4002-4008

Spandidos Publications

Access to resources Recommend Favorite

Association and prediction of severe 5-fluorouracil toxicity with dihydropyrimidine dehydrogenase gene polymorphisms: A meta-analysis

By    

Biomedical Reports, Vol. 3, Iss. 6, 2015-01 ,pp. : 879-883

Science Publishers

Access to resources Recommend Favorite

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer

By Tsuji Takashi   Sawai Terumitsu   Takeshita Hiroaki   Nakagoe Tohru   Hidaka Shigekazu   Yamaguchi Hiroyuki   Yasutake Toru   Nagayasu Takeshi   Tagawa Yutaka  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite